CEO Browne discusses integration challenges and HEMOBLAST transition amid margin pressures.
Xtant Medical Holdings, Inc. (XTNT) News
Latest headlines that mention XTNT, newest first · each headline opens the original publisher
- Last price
- $0.28
- Day change
- -2.55%
- Next earnings
- 2026-11-09
XTNT headlines
latest coverageXTNT news alerts
Get an alert by email or push when a new headline mentions XTNT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.